General Information	6 Months Ended
Jun. 30, 2025
General Information [Abstract]
General Information	1. General information 1.1. Nature of the business Silence Therapeutics plc and its subsidiaries, or together, the Group, are primarily involved in the discovery, delivery and development of RNA therapeutics. Silence Therapeutics plc, a public company limited by shares registered in England and Wales, with company number 02992058, is the Group’s ultimate parent company. The Company’s registered office is 27 Eastcastle Street, London, United Kingdom W1W 8DH and the principal place of business is 72 Hammersmith Road, London, United Kingdom W14 8TH.

General Information

6 Months Ended

Jun. 30, 2025

1. General information

1.1. Nature of the business

Silence Therapeutics plc and its subsidiaries, or together, the Group, are primarily involved in the discovery, delivery and development of RNA therapeutics. Silence Therapeutics plc, a public company limited by shares registered in England and Wales, with company number 02992058, is the Group’s ultimate parent company. The Company’s registered office is 27 Eastcastle Street, London, United Kingdom W1W 8DH and the principal place of business is 72 Hammersmith Road, London, United Kingdom W14 8TH.

Silence Therapeutics plc 10-Q